AMRN Amarin Corp Plc

Price (delayed)

$1.28

Market cap

$521.84M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.22

Enterprise value

$339.75M

Amarin is a rapidly growing, innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From its scientific research foundation to its focus on clinical trials, and now its ...

Highlights
The company's EPS rose by 15% QoQ
AMRN's net income is up by 14% from the previous quarter
Amarin's gross profit has decreased by 48% YoY and by 10% QoQ
The revenue is down by 33% year-on-year and by 2.3% since the previous quarter

Key stats

What are the main financial stats of AMRN
Market
Shares outstanding
407.69M
Market cap
$521.84M
Enterprise value
$339.75M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.89
Price to sales (P/S)
1.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.94
Earnings
Revenue
$360.54M
EBIT
-$91.95M
EBITDA
-$88.87M
Free cash flow
-$88.85M
Per share
EPS
-$0.22
Free cash flow per share
-$0.22
Book value per share
$1.44
Revenue per share
$0.89
TBVPS
$2.07
Balance sheet
Total assets
$860.19M
Total liabilities
$275.4M
Debt
$9.84M
Equity
$584.79M
Working capital
$439.58M
Liquidity
Debt to equity
0.02
Current ratio
2.8
Quick ratio
1.79
Net debt/EBITDA
2.05
Margins
EBITDA margin
-24.7%
Gross margin
60.5%
Net margin
-25.2%
Operating margin
-26.3%
Efficiency
Return on assets
-10%
Return on equity
-15.5%
Return on invested capital
-23.9%
Return on capital employed
-14.9%
Return on sales
-25.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMRN stock price

How has the Amarin stock price performed over time
Intraday
5.79%
1 week
7.56%
1 month
-9.22%
1 year
-12.33%
YTD
5.79%
QTD
-14.67%

Financial performance

How have Amarin's revenue and profit performed over time
Revenue
$360.54M
Gross profit
$218.02M
Operating income
-$94.9M
Net income
-$90.7M
Gross margin
60.5%
Net margin
-25.2%
Amarin's gross profit has decreased by 48% YoY and by 10% QoQ
The revenue is down by 33% year-on-year and by 2.3% since the previous quarter
AMRN's gross margin is down by 23% year-on-year and by 8% since the previous quarter
AMRN's net income is up by 14% from the previous quarter

Growth

What is Amarin's growth rate over time

Valuation

What is Amarin stock price valuation
P/E
N/A
P/B
0.89
P/S
1.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.94
The company's EPS rose by 15% QoQ
AMRN's P/B is 91% below its 5-year quarterly average of 9.5
The equity has declined by 9% year-on-year
The P/S is 82% less than the 5-year quarterly average of 7.9 but 11% more than the last 4 quarters average of 1.3
The revenue is down by 33% year-on-year and by 2.3% since the previous quarter

Efficiency

How efficient is Amarin business performance
Amarin's ROA has increased by 12% from the previous quarter
AMRN's ROE is up by 12% from the previous quarter
The ROIC has increased by 10% QoQ
The company's return on sales rose by 9% QoQ

Dividends

What is AMRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMRN.

Financial health

How did Amarin financials performed over time
AMRN's total liabilities is down by 17% year-on-year and by 5% since the previous quarter
AMRN's quick ratio is up by 13% year-on-year and by 5% since the previous quarter
AMRN's debt is 98% smaller than its equity
The equity has declined by 9% year-on-year
AMRN's debt is down by 5% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.